BIOVERATIV INC. Operating Income
BIOVERATIV INC. reported Operating Income of $447.20 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-14.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2018-02-14
- BIOVERATIV INC. operating income (loss) for the quarter ending 2017-12-31 was $117.90M, a 39.86% increase year-over-year.
- BIOVERATIV INC. operating income (loss) for the quarter ending 2017-09-30 was $103.80M, a 30.90% increase year-over-year.
- BIOVERATIV INC. operating income (loss) for the quarter ending 2017-06-30 was $113.60M, a 80.60% increase year-over-year.
- BIOVERATIV INC. operating income (loss) for the quarter ending 2017-03-31 was $111.90M, a 69.80% increase year-over-year.
- BIOVERATIV INC. operating income (loss) for fiscal 2017 was $447.20M, a 52.94% increase from fiscal 2016.
- BIOVERATIV INC. operating income (loss) for fiscal 2016 was $292.40M, a 198.37% increase from fiscal 2015.
- BIOVERATIV INC. operating income (loss) for fiscal 2015 was $98.00M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2017-12-31 | $117.90M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | $221.70M derived: sum of 2 quarters · filed 2018-02-14 | $335.30M derived: sum of 3 quarters · filed 2018-02-14 | $447.20M 10-K · filed 2018-02-14 |
| 2017-09-30 | $103.80M 10-Q · filed 2017-10-27 | $217.40M derived: sum of 2 quarters · filed 2017-10-27 | $329.30M 10-Q · filed 2017-10-27 | $413.60M derived: sum of 4 quarters · filed 2018-02-14 |
| 2017-06-30 | $113.60M 10-Q · filed 2017-08-03 | $225.50M 10-Q · filed 2017-08-03 | $309.80M derived: sum of 3 quarters · filed 2018-02-14 | $389.10M derived: sum of 4 quarters · filed 2018-02-14 |
| 2017-03-31 | $111.90M 10-Q · filed 2017-05-12 | $196.20M derived: sum of 2 quarters · filed 2018-02-14 | $275.50M derived: sum of 3 quarters · filed 2018-02-14 | $338.40M derived: sum of 4 quarters · filed 2018-02-14 |
| 2016-12-31 | $84.30M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | $163.60M derived: sum of 2 quarters · filed 2018-02-14 | $226.50M derived: sum of 3 quarters · filed 2018-02-14 | $292.40M 10-K · filed 2018-02-14 |
| 2016-09-30 | $79.30M 10-Q · filed 2017-10-27 | $142.20M derived: sum of 2 quarters · filed 2017-10-27 | $208.10M 10-Q · filed 2017-10-27 | |
| 2016-06-30 | $62.90M 10-Q · filed 2017-08-03 | $128.80M 10-Q · filed 2017-08-03 | ||
| 2016-03-31 | $65.90M 10-Q · filed 2017-05-12 | |||
| 2015-12-31 | $98.00M 10-K · filed 2018-02-14 |